SCHEMBL4604293

SCHEMBL4604293

NC(=O)Cc1cc[nH]c(=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.44
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CAPN1 P07384 1/20 0.38
NSD2 O96028 1/20 0.38
ABL1 P00519 1/20 0.38
PPARG P37231 1/20 0.38
RIN1 Q13671 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NCOR2 Q9Y618 1/20 0.38
NOTUM Q6P988 1/20 0.37
GRM2 Q14416 1/20 0.37
GRM3 Q14832 1/20 0.37
ALDH2 P05091 3/20 0.37
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
GPR84 Q9NQS5 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2837445 0.83 NSD2 (0.37) CAPN1NSD2ABL1PPARGRIN1
SCHEMBL4601886 0.81 CAPN1 (0.56) ALDH1A1CAPN1NSD2ABL1PPARG
SCHEMBL7657773 0.81 ALDH2 (0.40) ALDH1A1NSD2ABL1PPARGRIN1
SCHEMBL10056852 0.77 CYP2C9 (0.47) ALDH1A1ALDH2POLBMAPK1GPR84
SCHEMBL21550134 0.77 ALDH1A1 (0.49) ALDH1A1NSD2ABL1PPARGRIN1
SCHEMBL1161397 0.75
SCHEMBL2595424 0.75
SCHEMBL18460841 0.74 NSD2 (0.36) NSD2ABL1PPARGRIN1L3MBTL1
SCHEMBL4161939 0.74 SMN1; SMN2 (0.49) KDM4EALDH1A1L3MBTL1ALDH2LMNA
Hydrochloric Acid SCHEMBL3568937 0.74 GAA (0.46) CA2KDM4ENSD2ABL1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1915363-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS AstraZeneca AB (SE) 2008-04-30 EP claimed
WO-2007018469-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-02-15 WO claimed
EP-1915363-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS AstraZeneca AB (SE) 2008-04-30 EP disclosed
WO-2007018469-A1 OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2007-02-15 WO disclosed